188 related articles for article (PubMed ID: 38578040)
41. Machine learning reveals ferroptosis features and a novel ferroptosis classifier in patients with sepsis.
Chen Z; Wei S; Yuan Z; Chang R; Chen X; Fu Y; Wu W
Immun Inflamm Dis; 2024 May; 12(5):e1279. PubMed ID: 38780016
[TBL] [Abstract][Full Text] [Related]
42. Identification of immunity- and ferroptosis-related genes for predicting the prognosis of serous ovarian cancer.
Yuan X; Zhou Q; Zhang F; Zheng W; Liu H; Chen A; Tao Y
Gene; 2022 Sep; 838():146701. PubMed ID: 35777713
[TBL] [Abstract][Full Text] [Related]
43. Identification and validation of a ferroptosis-related gene signature for predicting survival in skin cutaneous melanoma.
Ping S; Wang S; Zhao Y; He J; Li G; Li D; Wei Z; Chen J
Cancer Med; 2022 Sep; 11(18):3529-3541. PubMed ID: 35373463
[TBL] [Abstract][Full Text] [Related]
44. Identification of a novel cuproptosis-related gene signature for multiple myeloma diagnosis.
Zhu Y; Chang S; Liu J; Wang B
Immun Inflamm Dis; 2023 Nov; 11(11):e1058. PubMed ID: 38018590
[TBL] [Abstract][Full Text] [Related]
45. A novel ferroptosis-related gene signature associated with cell cycle for prognosis prediction in patients with clear cell renal cell carcinoma.
Chen S; Zhang E; Guo T; Shao J; Wang T; Zhang N; Wang X; Zheng J
BMC Cancer; 2022 Jan; 22(1):1. PubMed ID: 34979993
[TBL] [Abstract][Full Text] [Related]
46. The level of bone marrow WT1 message is a useful marker to differentiate myelodysplastic syndromes with low blast percentage from cytopenia due to other reasons.
Baba M; Hata T; Tsushima H; Mori S; Sasaki D; Turuta K; Hasegawa H; Ando K; Sawayama Y; Imanishi D; Taguchi J; Yanagihara K; Tomonaga M; Kamihira S; Miyazaki Y
Intern Med; 2015; 54(5):445-51. PubMed ID: 25758068
[TBL] [Abstract][Full Text] [Related]
47. Machine Learning Revealed Ferroptosis Features and a Novel Ferroptosis-Based Classification for Diagnosis in Acute Myocardial Infarction.
Huang D; Zheng S; Liu Z; Zhu K; Zhi H; Ma G
Front Genet; 2022; 13():813438. PubMed ID: 35145551
[TBL] [Abstract][Full Text] [Related]
48. Challenges in Diagnosing Myelodysplastic Syndromes in the Era of Genetic Testing: Proceedings of the 13th Workshop of the European Bone Marrow Working Group.
Hebeda KM; Tzankov A; Boudova L; Saft L; Hasserjian RP; de Boer M; Fend F; Orazi A; Leguit R
Pathobiology; 2019; 86(1):62-75. PubMed ID: 29982244
[TBL] [Abstract][Full Text] [Related]
49. Over expression of mTOR gene predicts overall survival in myelodysplastic syndromes.
Maurya N; Mohanty P; Panchal P; Shanmukhaiah C; Vundinti BR
Mol Biol Rep; 2023 Jan; 50(1):235-244. PubMed ID: 36322239
[TBL] [Abstract][Full Text] [Related]
50. A machine learning approach to predicting risk of myelodysplastic syndrome.
Radhachandran A; Garikipati A; Iqbal Z; Siefkas A; Barnes G; Hoffman J; Mao Q; Das R
Leuk Res; 2021 Oct; 109():106639. PubMed ID: 34171604
[TBL] [Abstract][Full Text] [Related]
51. Prediction of overall survival based upon a new ferroptosis-related gene signature in patients with clear cell renal cell carcinoma.
Sun Z; Li T; Xiao C; Zou S; Zhang M; Zhang Q; Wang Z; Zhan H; Wang H
World J Surg Oncol; 2022 Apr; 20(1):120. PubMed ID: 35422048
[TBL] [Abstract][Full Text] [Related]
52. A novel ferroptosis-related gene signature can predict prognosis and influence immune microenvironment in acute myeloid leukemia.
Huang X; Zhou D; Ye X; Jin J
Bosn J Basic Med Sci; 2022 Jul; 22(4):608-628. PubMed ID: 34784264
[TBL] [Abstract][Full Text] [Related]
53. [Pathogenesis and treatment of immune dysregulation associated with myelodysplastic syndromes].
Nakajima H
Rinsho Ketsueki; 2023; 64(8):753-763. PubMed ID: 37673628
[TBL] [Abstract][Full Text] [Related]
54. Discriminating myelodysplastic syndrome and other myeloid malignancies from non-clonal disorders by multiparametric analysis of automated cell data.
Kim SY; Park Y; Kim H; Kim J; Kwon GC; Koo SH
Clin Chim Acta; 2018 May; 480():56-64. PubMed ID: 29378171
[TBL] [Abstract][Full Text] [Related]
55. Identification and validation of a novel ferroptosis-related gene model for predicting the prognosis of gastric cancer patients.
Liu G; Ma JY; Hu G; Jin H
PLoS One; 2021; 16(7):e0254368. PubMed ID: 34252149
[TBL] [Abstract][Full Text] [Related]
56. [Diagnosis and treatment of childhood myelodysplastic syndrome].
Hasegawa D
Rinsho Ketsueki; 2021; 62(4):229-238. PubMed ID: 33967145
[TBL] [Abstract][Full Text] [Related]
57. Multiparameter flow cytometry is instrumental to distinguish myelodysplastic syndromes from non-neoplastic cytopenias.
Cremers EMP; Westers TM; Alhan C; Cali C; Wondergem MJ; Poddighe PJ; Ossenkoppele GJ; van de Loosdrecht AA
Eur J Cancer; 2016 Feb; 54():49-56. PubMed ID: 26720403
[TBL] [Abstract][Full Text] [Related]
58. Integrated Single-cell and Bulk RNA Sequencing Analysis Cross Talk between Ferroptosis-related Genes and Prognosis in Oral Cavity Squamous Cell Carcinoma.
Lan T; Ren S; Hu H; Wang R; Chen Q; Wu F; Xu Q; Li Y; Shao L; Wang L; Liu X; Cao H; Li J
Recent Pat Anticancer Drug Discov; 2024; 19(3):354-372. PubMed ID: 38214321
[TBL] [Abstract][Full Text] [Related]
59. Construction and validation of a novel Ferroptosis-related gene signature predictive model in rectal Cancer.
Shi WK; Liu YX; Qiu XY; Zhou JY; Zhou JL; Lin GL
BMC Genomics; 2022 Nov; 23(1):764. PubMed ID: 36414988
[TBL] [Abstract][Full Text] [Related]
60. Machine learning-based integration identifies the ferroptosis hub genes in nonalcoholic steatohepatitis.
Dai L; Yuan W; Jiang R; Zhan Z; Zhang L; Xu X; Qian Y; Yang W; Zhang Z
Lipids Health Dis; 2024 Jan; 23(1):23. PubMed ID: 38263097
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
